We are live on
!
Find out more
A
Astrantus Portfolio holdings
AUM
$59.4M
This Fund
S&P 500
This Quarter
Est. Return
-5.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.4M
AUM Growth
-$74.2M
(-56%)
Cap. Flow
-$69.6M
Cap. Flow
% of AUM
-117%
Top 10 Holdings %
Top 10 Hldgs %
8.09%
Holding
327
New
119
Increased
16
Reduced
36
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$523K |
| 2 |
Home Depot
HD
|
+$520K |
| 3 |
Wells Fargo
WFC
|
+$519K |
| 4 |
Unilever
UL
|
+$515K |
| 5 |
Bank of America
BAC
|
+$514K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.49M |
| 2 |
Zebra Technologies
ZBRA
|
+$1.49M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.45M |
| 4 |
Duke Energy
DUK
|
+$1.44M |
| 5 |
Alibaba
BABA
|
+$1.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.49% |
| 2 | Healthcare | 14.97% |
| 3 | Technology | 14.75% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 12.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$712B
| $488K | 0.82% |
+2,200
| New | +$476K |
|
2
Vale
VALE
$64B
| $486K | 0.82% |
+24,300
| New | +$421K |
|
3
Merck
MRK
$366B
| $484K | 0.81% |
5,900
-6,488
| -52% | -$512K |
|
4
Verizon
VZ
$208B
| $484K | 0.81% |
9,500
+4,620
| +95% | +$245K |
|
5
Novartis
NVS
$292B
| $483K | 0.81% |
5,500
-5,061
| -48% | -$438K |
|
6
AT&T
T
$178B
| $480K | 0.81% |
26,877
+15,226
| +131% | +$282K |
|
7
Johnson & Johnson
JNJ
$646B
| $479K | 0.81% |
2,700
| – | – |
|
8
Boston Scientific
BSX
$67.9B
| $478K | 0.8% |
+10,800
| New | +$468K |
|
|
9
Unilever
UL
$140B
| $474K | 0.8% |
+9,244
| New | +$515K |
|
10
Abbott
ABT
$195B
| $473K | 0.8% |
+4,000
| New | +$496K |
|
11
Apple
AAPL
$4.67T
| $471K | 0.79% |
+2,700
| New | +$454K |
|
|
12
Bank of America
BAC
$436B
| $470K | 0.79% |
+11,400
| New | +$514K |
|
|
13
Wells Fargo
WFC
$262B
| $470K | 0.79% |
+9,700
| New | +$519K |
|
14
Toronto Dominion Bank
TD
$199B
| $469K | 0.79% |
+5,900
| New | +$475K |
|
15
US Bancorp
USB
$97.3B
| $468K | 0.79% |
+8,800
| New | +$506K |
|
16
Truist Financial
TFC
$61.6B
| $465K | 0.78% |
+8,200
| New | +$507K |
|
|
SCHW
17
Charles Schwab
SCHW
$191B
| $464K | 0.78% |
+5,500
| New | +$484K |
|
18
Equinor
EQNR
$98.2B
| $461K | 0.78% |
12,300
-908
| -7% | -$28.2K |
|
|
FITB
19
Fifth Third Bancorp
FITB
$49.5B
| $461K | 0.78% |
10,700
+3,106
| +41% | +$145K |
|
|
BNY
20
Bank of New York Mellon
BNY
$110B
| $457K | 0.77% |
+9,200
| New | +$523K |
|
21
Zoetis
ZTS
$32B
| $453K | 0.76% |
2,400
-1,400
| -37% | -$277K |
|
22
ON Semiconductor
ON
$28.3B
| $451K | 0.76% |
7,200
-485
| -6% | -$29.6K |
|
23
TC Energy
TRP
$64.4B
| $451K | 0.76% |
+8,000
| New | +$421K |
|
24
Baxter International
BAX
$13.5B
| $450K | 0.76% |
5,800
-2,803
| -33% | -$235K |
|
|
25
Home Depot
HD
$329B
| $449K | 0.76% |
+1,500
| New | +$520K |
|
Similar funds
AAI
TLCM
LSC
ALFA
IMF
DCM
SCMU
EA
Astrantus's Q1 2022 Portfolio in Review
As of Q1 2022, Astrantus held 327 positions worth $59.4M, down 56% from $134M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Astrantus withdrew a net $69.6M in Q1 2022, closing 155 positions and reducing 36 holdings. Its most notable exit was TSMC, an estimated $1.49M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Astrantus opened a new position in Bank of New York Mellon worth $457K.
- Astrantus's largest Q1 2022 buy was Bank of New York Mellon: 9,200 shares worth $457K.
- Astrantus added most to AT&T in Q1 2022, an estimated $282K increase.
- Astrantus's biggest Q1 2022 reduction was CVS Health, cutting an estimated $1.1M.
- Astrantus fully exited TSMC in Q1 2022, selling an estimated $1.49M.
- Astrantus's ten largest holdings make up 8.1% of its $59.4M portfolio in Q1 2022.
- Astrantus opened 119 new positions and closed 155 in Q1 2022.
- Astrantus's portfolio value fell 56% quarter-over-quarter to $59.4M.
Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.